Shareholders Will Be Pleased With The Quality of Xeris Biopharma Holdings' (NASDAQ:XERS) Earnings
Xeris Biopharma Holdings Inc XERS
$6.01
▼ -3.69%
($-0.23)
Open
$6.25
Prev Close
$6.24
Day Range
$5.97 – $6.27
52W Range
$4.30 – $10.08
Market Cap
$1.05B
P/E (TTM)
1,944.56
Beta
0.76
EPS (TTM)
$-0.02
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-06-21 |
| Shares Out. | 172,430,000 |
| Website | xerispharma.com/ ↗ |
| Phone | 18444455704 |
Xeris Biopharma Holdings Inc is a publicly traded company under the ticker symbol XERS on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-05-01)
📰 Latest News for XERS
Results: Xeris Biopharma Holdings, Inc. Confounded Analyst Expectations With A Surprise Profit
Xeris Biopharma Q1 Earnings Call Highlights
Xeris Biopharma Holdings, Inc. Q1 2026 Earnings Call Summary
Xeris Biopharma Holdings (XERS) Is Up 8.2% After Swing to Q1 Profitability - What's Changed
Xeris (XERS) Q1 2026 Earnings Call Transcript
Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call Transcript
Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates